Acquiring Company
CoaguSense
Acquired Company
DOASENSE GmbH
Fremont
HeidelbergBiotechnologyHealth CareMedicalTherapeuticsBiotechnologyHealth CareMedical DeviceHealth DiagnosticsDescription
CoaguSense, Inc. has announced its agreement to acquire the DOASENSE DOAC testing business. This strategic acquisition will enhance CoaguSense’s portfolio by including rapid testing for Direct Oral Anticoagulants. The acquisition is expected to close within the next 12 months, pending customary conditions. This move supports CoaguSense’s mission to advance its global growth strategy in anticoagulation monitoring.
Quick answer
CoaguSense is acquiring DOASENSE GmbH, announced March 23, 2026. CoaguSense is based in Fremont, California, United States.
- How much did CoaguSense pay for DOASENSE GmbH?
- The deal value was not disclosed.
- What does CoaguSense do?
- CoaguSense, Inc. is a leading developer of point-of-care coagulation monitoring systems.
- Where are CoaguSense and DOASENSE GmbH based?
- CoaguSense is based in Fremont, California, United States. DOASENSE GmbH is based in Heidelberg, Baden Württemberg, Germany.
- Who are the decision-makers at CoaguSense?
- Fundz holds 2 contacts at CoaguSense. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Other recent acquisitions in Medical and Therapeutics
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- Medimaps Group merges with Radiobotics for AI growth (March 2, 2026)
- Image Plus acquires Island Radiology for $100m, $100M (May 1, 2026)
- Advanced Bifurcation Systems Acquires Svelte Medical (April 27, 2026)
- Embecta to acquire Owen Mumford Holdings Limited (March 19, 2026)
- Mainz Biomed N.V. Acquires Quantum Cyber to Enhance Cybersecurity Strategy (March 17, 2026)
- Sensei Biotherapeutics acquires Faeth Therapeutics (February 18, 2026)
Who to call at CoaguSense, and when
When CoaguSense changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day CoaguSense raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at CoaguSense, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at CoaguSense. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment CoaguSense makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired DOASENSE GmbH?
DOASENSE GmbH was acquired by CoaguSense, based in Fremont. The deal was reported on March 23, 2026. CoaguSense, Inc. is a leading developer of point-of-care coagulation monitoring systems. The company focuses on providing actionable information at the point of care for patients with coagulation disorders. CoaguSense is privately held and operates in Biotechnology.
When did CoaguSense acquire DOASENSE GmbH?
CoaguSense's acquisition of DOASENSE GmbH was reported on March 23, 2026. CoaguSense, Inc. has announced its agreement to acquire the DOASENSE DOAC testing business. This strategic acquisition will enhance CoaguSense’s portfolio by including rapid testing for Direct Oral Anticoagulants. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does DOASENSE GmbH do?
DOASENSE GmbH is a pioneer in specialized diagnostic solutions for Direct Oral Anticoagulants (DOACs). The company develops innovative testing technology, including the DOAC Dipstick for rapid point-of-care testing. It is privately held, operating in Biotechnology, and is based in Heidelberg.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.